Op-ed: Trump should right Biden’s wrongs on Medicare reimbursement
By Kelley Koch | Published November 15, 2025 in The Gazette
As a former health care administrator, I’m deeply concerned about an impending consequence brought on by Biden’s Inflation Reduction Act that threatens seniors in nursing homes and assisted living facilities.
Long-term care pharmacies — the pharmacies that serve senior care facilities — provide specialized care that cannot be replicated: consultant pharmacist services, specialized patient-specific medication packaging, and 24/7 medication delivery. These aren’t extras, they’re federally mandated services that nursing homes and assisted living facilities must provide to residents.
Beginning in January, Medicare reimbursement changes will drastically cut payments to these specialized pharmacies, putting nearly 60% of them at risk of closure. Without these pharmacies, nursing homes may be unable to meet federal requirements and could be forced to close themselves, particularly in rural areas where a single pharmacy closure could impact multiple facilities serving our most vulnerable seniors.
I hope President Trump will right this wrong brought on by the Biden administration by taking executive action to provide relief to these pharmacies and I hope our congressional delegation will support recently introduced bipartisan legislation which would protect seniors’ access to these critical services.
Time is running out — Washington must act to protect our seniors.
Read the full article on The Gazette here
Recent Posts
-
IRA Drug Supply Fee Bill For LTC Pharmacies Could Prevent $4.8B Cost To Taxpayers
Long-term care (LTC) pharmacies are stepping up their calls for Congress to pass the bipartisan, bicameral Preserving Patient Access to Long-Term Care Pharmacies Act with the release of a new analysis Monday (Nov. 17) by the Senior Care Pharmacy Coalition (SCPC) that found failure to ensure LTC pharmacies are not negatively impacted when new maximum fair prices for select Medicare Part D drugs become effective next year may cost taxpayers up to $4.8 billion in increased health care costs over the next decade.
-
Op-ed: I promised to fight for common-sense policies rooted in our core conservative principles
When I ran for office, I promised that I would fight for common-sense policies rooted in our core conservative principles. That means protecting our citizens and ensuring that we keep the good-paying jobs that sustain our communities. Right now, I’m concerned about how upcoming changes to Medicare Part D reimbursement will affect long-term care pharmacies in our state.
-
Failing to Address Looming Long-Term Care Crisis Will Leave Seniors in Nursing Homes Without Access to Essential Prescription Drugs and Services and Cost Taxpayers Up to $4.8 Billion
Washington, DC (November 18, 2025) — A new analysis from the Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, shows that if Congress does not pass the Preserving Patient Access to Long-Term Care Pharmacies Act this year, it could cost taxpayers up to $4.8 billion in increased healthcare costs over the next decade. Inaction is two to five times the cost of the Act (H. R. 5031 in the House, S. 3159 in the Senate) to avert a crisis in quality of and access to care next year.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.